Higher respose rates for the lower dose of drug...

[Olga]

It came to y attention that in this study the lower dose of the new tyrosine kinase drug Nilotinib was consistently found to get better response (300 mg versus 400 mg twice daily)
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
http://content.nejm.org/cgi/content/abs ... 62/24/2251
so I was wondering if this might be the case with the cediranib as well?